Glucagon-Like Peptide-1 Receptor Agonists and Human Fertility: Mechanisms, Evidence, and Clinical Implications Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are well established for the treatment of type 2 diabetes mellitus and obesity. Increasingly, reports suggest a possible association between GLP-1 RA use and
Tag: Polycystic ovary syndrome
Exploring Better Therapies For Polycystic Ovary Syndrome: The Role Of Anti-Obesity Medications
Exploring Better Therapies For Polycystic Ovary Syndrome: The Role Of Anti-Obesity Medications Overview This systematic review and meta-analysis aimed to assess the efficacy of anti-obesity agents in addressing hormonal, reproductive, metabolic, and psychological outcomes in women with polycystic ovary syndrome (PCOS), with the objective of informing updates to the International Evidence-based Guideline
